首页> 外文期刊>International Journal of Nanomedicine >Engineering of Long-Term Stable Transparent Nanoemulsion Using High-Gravity Rotating Packed Bed for Oral Drug Delivery
【24h】

Engineering of Long-Term Stable Transparent Nanoemulsion Using High-Gravity Rotating Packed Bed for Oral Drug Delivery

机译:使用高重旋转覆盖床进行长期稳定透明纳米乳液,用于口服药物递送

获取原文
获取外文期刊封面目录资料

摘要

Background: Oil-in-water drug nanoemulsion forms drug delivery systems with high oral bioavailability. The conventional fabrication methods of nanoemulsion are low energy emulsification methods and high energy emulsification methods. However, both two methods are not ideal for industrial production. The problem of low energy emulsification methods is the high dosage of surfactant and co-surfactant which has potential biosecurity issues. What?is more, high energy emulsification methods have some disadvantages, like the destruction of drug components, the price of equipment and the difficulties of industrial production. Hence, there have been a few commercial drug nanoemulsions so far. Methods: In this work, we reported a novel method for the fabrication of stable and transparent drug nanoemulsion which contains hydrophilic drug rosuvastatin?(ROS) calcium or hydrophobic drug silybinin?(SYN) by using high-gravity rotating packed bed (RPB). The drug nanoemulsion was systematically characterized by droplet size, size distribution, stability and in vitro drug release as well as Caco-2 cells permeability. Results: Compared with the self-emulsification method (SE), high-gravity technology could reduce 75% amount of mixed surfactants. The as-prepared nanoemulsion exhibited a very narrow droplet size distribution with a size of 13.53?± 0.53 nm and a polydispersity index of 0.073?± 0.018. Meanwhile, the drug nanoemulsion was physicochemically stable at 25°C and 4°C for one-year storage. Furthermore, both ROS and SYN nanoemulsion displayed higher cell permeability and in vitro dissolution than that of commercial formulations. Conclusion: These results demonstrate that RPB can be a potential device to facilitate the industrial production of drug nanoemulsion.
机译:背景:水性药物纳米乳液形成具有高口腔生物利用度的药物递送系统。纳米乳液的常规制造方法是低能量乳化方法和高能量乳化方法。然而,两种方法都不适合工业生产。低能量乳化方法的问题是具有潜在生物安全问题的表面活性剂和共表面活性剂的高剂量。什么?更高,高能乳化方法有一些缺点,如破坏药物组件,设备价格和工业生产困难。因此,到目前为止已经有一些商业药物纳米乳液。方法:在这项工作中,我们报道了一种新的方法,用于制造稳定透明的药物纳米乳液,其含有亲水药物罗萨杨蛋白α(ROS)钙或疏水药物Silybinin?(SYN)通过使用高重旋转填充床(RPB)。通过液滴尺寸,尺寸分布,稳定性和体外药物释放以及CaCO-2细胞渗透性,系统地表征了药物纳米乳液。结果:与自乳化方法(SE)相比,高重力技术可降低75%的混合表面活性剂。制备的纳米乳液表现出非常窄的液滴尺寸分布,尺寸为13.53Ω·0.53nm和0.073Ω018的多分散指数。同时,药物纳米乳液在25℃和4℃下在25℃和4℃下物理储存。此外,ROS和SYN纳米乳液均显示出更高的细胞渗透性和体外溶解,而不是商业制剂的渗透。结论:这些结果表明RPB可以是促进药物纳米乳液的工业生产的潜在装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号